Article
Evaluation of mutation screening as a first line test for the diagnosis of the primary hyperoxalurias.
Kidney international - 1 Sept 2004
Rumsby Gill, Williams Emma, Coulter-Mackie Marion
Abstract excerpt
BACKGROUND: A definitive diagnosis of primary hyperoxaluria type 1 (PH1) and primary hyperoxaluria type 2 (PH2) requires the measurement of alanine:glyoxylate aminotransferase (AGT) and glyoxylate reductase (GR) activities, respectively, in a liver biopsy. We have evaluated a molecular genetic approach for the diagnosis of these autosomal-recessive diseases. METHODS: Polymerase chain reaction (PCR) was used to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
